Emergent BioSolutions is currently navigating a challenging period characterized by weak earnings, high leverage, and a major restructuring effort following a difficult 2024. The company is actively shifting its focus from lower-margin contract manufacturing towards core medical countermeasures, primarily for the U.S. government, while addressing operational and reputational issues from its former role in COVID-19 vaccine production. Management is prioritizing cost reductions, debt alleviation, and optimizing its product mix to improve profitability and cash flow.

Dr. Sanjay Basu, Senior Director of GPU & Gen AI Solutions & Services – Cloud Engineering at Oracle, is confirmed to speak at TCW LIVE! The panel will discuss how the accelerating demand for AI is reshaping digital infrastructure, driving significant investments, and fostering new partnerships among hyperscalers, data center providers, and neocloud companies. The discussion will cover critical considerations like power availability, site selection, and fiber connectivity in building resilient AI ecosystems.

The average 12-month price target for Dave & Buster's Entertainment, Inc. stock has been reduced from $20.33 to $18.78, according to estimates from 9 analysts. This new target implies a potential upside of approximately 52% based on the June 15 closing price. The consensus rating for the company remains "Buy" among 11 covering analysts.

East West Bancorp (EWBC) is drawing investor attention as its latest quarterly earnings are scrutinized for insights into net interest margin, loan growth, and credit quality amid fluctuating interest rates. The regional lender's performance is closely watched by investors and analysts, with key metrics like capital strength, deposit stability, and efficiency ratio influencing its market valuation compared to peers. Future quarterly reports on margin, credit quality, and capital deployment will be crucial in shaping sentiment for the stock in a dynamic US economic and regulatory environment.

CSX Corp. shares are trading near recent 52-week highs on the Nasdaq, driven by strong profitability and cost discipline despite fluctuating freight demand. The company's first-quarter 2026 earnings showed stable profits and continued commitment to shareholder returns through dividends and share repurchases. Analysts maintain a constructive but selective stance, recognizing CSX's efficient cost structure and cash flow generation, while acknowledging macro-sensitive freight categories as potential risks.

On a quiet Tuesday with no new earnings or rating headlines, Trimble Inc. stock is drawing attention for its valuation, fundamentals, and strategic positioning in key growth markets like construction, geospatial, and transportation. The company continues to expand its ecosystem and brand visibility through events such as Trimble Insight Europe 2026 and the annual Construction Innovation Awards. This focus on platform building and community engagement is seen as supportive of long-term growth and customer retention, even as short-term stock movements are more influenced by broader market sentiment.

Waters Corporation is gaining attention following its early June 2026 launch of new analytical products in bioseparation and mass spectrometry, including BioResolve and GTxResolve columns, and Xevo MRT P10 and Cyclic IMS P20 mass spectrometers. These new offerings position Waters deeper into higher-value applications like biologics and impurity analysis, driving demand beyond routine lab replacements. While the stock continues to trade near recent levels on the NYSE under WAT, the product momentum, rather than a single earnings surprise, is currently shaping investor sentiment.

Raymond James initiated coverage on Aktis Oncology (AKTS) with a Strong Buy rating and a $40 price target. This positive outlook is based on the company's radioligand therapy (RLT) platform and its collaboration with Eli Lilly. Following this news, Aktis Oncology shares traded higher.

J.B. Hunt's 360 Platform is rolling out enhanced digital freight tools to give shippers and carriers more control, transparent pricing, and faster decision-making in the challenging transportation market. Key features include real-time load visibility, automated pricing, and streamlined document handling, aiming to improve efficiency and reduce costs for both parties. This digital initiative is a strategic pillar for J.B. Hunt Transport, focusing on optimizing efficiency, supporting multimodal offerings, and strengthening relationships with enterprise shippers.

Cummins Inc. (NYSE:CMI) shares rose 3% after announcing a deal with Circe Energy to supply natural gas generator sets for a data center campus in West Texas. This agreement addresses the increasing demand for on-site power generation in data centers due to utility interconnection delays and grid constraints, positioning Cummins to capitalize on the growing needs of AI and power-intensive digital infrastructure. Deliveries are scheduled from 2026 through 2030, utilizing Cummins’ HSK78 and QSK60 generator set platforms as the primary power source for the facility.